| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BRKR | Common Stock | Options Exercise | $52,075 | +2,500 | +11% | $20.83 | 25,647 | 15 Aug 2024 | Direct | |
| transaction | BRKR | Common Stock | Options Exercise | $240,000 | +10,000 | +39% | $24.00 | 35,647 | 15 Aug 2024 | Direct | |
| transaction | BRKR | Common Stock | Sale | $295,748 | -4,684 | -13% | $63.14 | 30,963 | 15 Aug 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BRKR | Stock Option (Right to Purchase) | Options Exercise | $0 | -2,500 | -100% | $0.000000* | 0 | 15 Aug 2024 | Common Stock | 2,500 | $20.83 | Direct | F2 |
| transaction | BRKR | Stock Option (Right to Purchase) | Options Exercise | $0 | -10,000 | -100% | $0.000000* | 0 | 15 Aug 2024 | Common Stock | 10,000 | $24.00 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.81 to $63.28, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The Stock Option granted to the Reporting Person on November 12, 2015 (the "Original Grant Date") vests in equal installments on the first, second and third anniversaries of the Original Grant Date. |
| F3 | The Stock Option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vests in equal installments on the first, second and third anniversaries of the Original Grant Date. |